Prostate Cancer Clinical Trials in Los Angeles

Showing 1-20 of 325 trials

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

NCT06395753

The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.

Debiopharm International SA55 participantsStarted May 2024

Mesa, Arizona, United States • Queen Creek, Arizona, United States • Bakersfield, California, United States +19 more locations

Not Yet RecruitingNA< 1 mile

WATER IV PCa (AS Sub-study)

NCT07650448

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Localized Prostate Cancer

PROCEPT BioRobotics333 participantsStarted Sep 2026

Chandler, Arizona, United States • Los Angeles, California, United States • Boulder, Colorado, United States +14 more locations

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

WATER IV PCa (AS Sub-study)

Prostate Cancer Trials in Other Cities

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

FOG-001 in Locally Advanced or Metastatic Solid Tumors

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

HIFU for Focal Ablation of Prostate Tissue: An Observational Study

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

Other Conditions in Los Angeles